leadf
logo-loader
viewAlbert Labs

Albert Labs looking to investigate the use of psychedelics to treat anxiety in cancer patients

Albert Labs Chief Medical Officer Dr. Malcom Barratt-Johnson joined Steve Darling from Proactive to share details about the private company with a focus on the emerging field of psychedelic-assisted therapy and research. Dr. Barratt-Johnson talks about the origins of Albert Labs and about their recent news the company has done a reverse takeover of ME Resource Corp.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Albert Labs named herein, including the promotion by the Company of Albert Labs in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Red Rock Resources advancing towards a Canadian IPO with its Power Metal...

Red Rock Resources PLC (LON:RRR) Chairman Andrew Bell tells Proactive the group has begun the Canadian listing process for its joint venture with Power Metal Resources (LON:POW), Red Rock Australasia Pty Ltd.   Bell says the group is looking to list on the Toronto Stock Exchange...

8 hours, 33 minutes ago

2 min read